Alteogen to issue bonus shares to compensate for losses from dubious short sale

Pulse 2022. 10. 11. 15:24
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

[Source: Alteogen]
Alteogen, a Korean developer of biobetters, Tuesday said it has decided to gift 0.2 bonus shares for every one common share to shareholders to compensate for the plunge in stock prices from short selling.

The company will issue 8.58 million new common shares as bonus shares to the shareholders of record on Oct. 26. The new shares will be listed on Nov. 14.

The decision aims to repair the shareholder damage caused by dubious short sale activities. The company said rumors had been intentionally spread about its license deal with a global pharmaceutical company being canceled to drive down its stock price.

The company has filed a complaint with the Financial Supervisory Service on Monday.

“We feel apologetic to the shareholders who have suffered great damage from the drop in the stock price due to short sales,” said Alteogen’s CEO Park Soon-jae denying any changes in the company’s fundamentals.

The Kosdaq-trading shares however continued to slide, losing 3 percent Tuesday to 36,500 won.

[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?